MedTrace Logo

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

NCT00096590 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-05-12

No results posted yet for this study

Summary

RATIONALE: A test that detects abnormal blood clotting in patients with cancer may help doctors plan cancer surgery.

PURPOSE: This laboratory study is looking at a new blood test to detect abnormal clotting in patients with metastatic cancer undergoing surgery.

Conditions

  • Thromboembolism
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

OTHER

coagulation study

OTHER

immunoenzyme technique

OTHER

laboratory biomarker analysis

OTHER

physiologic testing

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • McDonald K. Horne, MD · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00096590 on ClinicalTrials.gov